Your browser doesn't support javascript.
loading
Phase 3 trial results bring hope for patients with IgA nephropathy.
Haraldsson, Börje.
Affiliation
  • Haraldsson B; Institute of Neuroscience and Physiology, University of Gothenburg, 405 30 Gothenburg, Sweden. Electronic address: borje.haraldsson@gu.se.
Lancet ; 402(10405): 827-829, 2023 09 09.
Article in En | MEDLINE | ID: mdl-37591290
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, IGA Limits: Humans Language: En Journal: Lancet Year: 2023 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, IGA Limits: Humans Language: En Journal: Lancet Year: 2023 Document type: Article Country of publication: United kingdom